Vancouver, British Columbia – October 24, 2025 – TheNewswire - Generation Uranium Inc. (TSXV: GEN) (the “Company”) or “Generation” wishes to clarify the disclosure in its news release dated October 17, 2025, announcing the closing of the second and final tranche of its non-brokered private placement (the “Offering”).In connection with the Offering a finder’s fee was paid in the first tranche to Haywood Securities Inc., consisting of $1,200, and 24,000 broker warrants. For the second tranche, Generation paid ...

Core Points - Plaid Technologies Inc. has successfully closed the first tranche of its non-brokered private placement, issuing 680,800 common shares at a price of $1.25 per share, resulting in gross proceeds of $851,000 [1][2] Group 1: Offering Details - The first tranche of the Offering does not involve any finder's fees and is subject to a statutory hold period of four months and one day, expiring on February 25, 2026 [2] - The Company plans to complete the remaining balance of the Offering in the near future [2] Group 2: Use of Proceeds - The net proceeds from the Offering will be used to supplement previously disclosed funding needs, providing additional working capital and extending the runway for technology development, sales, marketing, and potential graphene inventory purchases [3] Group 3: Company Overview - Plaid Technologies focuses on developing and commercializing graphene-enhanced technology, particularly a proprietary graphene-infused concrete mixture aimed at wellbore cement and subsurface applications [5]

Core Viewpoint - Beauce Gold Fields is closing a non-brokered private placement of 19,132,600 units at a price of $0.04 per unit, raising gross proceeds of $765,304, aimed at financing exploration and general corporate purposes [1][2]. Group 1: Private Placement Details - The private placement was announced on September 17, 2025, and was open to existing shareholders as of September 16, 2025, with subscriptions exceeding the required minimum [1]. - Existing shareholders contributed $376,304, while accredited investors accounted for the remaining $389,000 [1]. - Each unit consists of one common share and one common share purchase warrant, allowing the holder to purchase one common share at $0.10 for 24 months post-closing [2]. Group 2: Use of Proceeds - Proceeds from the placement will be allocated for exploration and general corporate purposes, with a maximum of 10% designated for investor relations activities [4]. - No proceeds will be used for payments to non-arm's length parties or for investor relations activities [4]. Group 3: Finder's Fees and Warrants - The company will pay finder’s fees of $800 to Canaccord Genuity Corp and $51,300 to EMD Financial Inc, along with issuing 16,000 and 1,026,000 warrants to these firms, respectively [3]. - The warrants will also allow the purchase of common shares at $0.10 for 24 months, subject to a four-month and one-day hold period [3]. Group 4: Company Overview - Beauce Gold Fields focuses on exploring and developing the largest placer gold district in eastern North America, with its flagship property being the Saint-Simon-les-Mines gold project [5]. - The company aims to trace old placer gold workings back to a bedrock source to uncover economic lode gold deposits [5]. - The Beauce region has a historical significance in gold mining, having produced some of the largest gold nuggets in Canadian history [5].

Vancouver, B.C. – October 24, 2025 – TheNewswire - IDEX Metals Corp. ("IDEX" or the "Company") (TSXV: IDEX; OTCQB: IDXMF) is pleased to announce the closing of its non-brokered private placement offering (the “Offering”), as previously disclosed in the Company’s news releases dated October 15, 2025 and October 22, 2025. In connection with the Offering, the Company issued 8,867,099 units (the “Units”) at a price of $0.60 per Unit, generating aggregate gross proceeds of approximately $5,320,259.Clayton Fishe ...

Financial Performance - Uniserve Communications Corporation reported Q1 fiscal 2026 revenues of $2,122K, an increase from $1,651K in the same period of the previous fiscal year, representing a growth of approximately 28.5% [1][2] - The net loss for Q1 fiscal 2026 was $264K, compared to a net loss of $112K for the same period in the prior year, indicating a worsening of financial performance [1][2] Operational Focus - The company aims to enhance its operating results in fiscal 2026 by implementing operational efficiencies, growing recurring revenues, and increasing value-added services for customers [1] Service Offerings - Uniserve provides a range of IT solutions and services for residential, small business, and enterprise customers, including telecommunications, high-speed internet, and managed IT services [3]

Core Insights - Ventripoint Diagnostics Ltd. is focused on advancing its VMS+™ cardiac diagnostic solutions towards commercial growth and clinical adoption following regulatory approval [3][5][39] - The company is actively seeking capital to support its updated business plan and commercialization efforts [2][34] Business Plan - The primary goal is to transition VMS+™ from research applications to routine clinical use, with an emphasis on upgrading existing sites to VMS+™ V4 [3][4] - The company aims to enhance its market presence in the Congenital Heart Defect (CHD) segment while expanding the system's applicability to other cardiac conditions [5][6] Commercialization Efforts - Ventripoint is expanding its commercial team and has engaged experienced candidates to drive sales growth [9] - The sales process is being updated to include a Device-as-a-Service (DaaS) subscription model, which is expected to reduce friction and create recurring revenue [15][39] Marketing Strategy - The marketing function has evolved to better align with market needs and improve customer engagement [10] - Customer training and support are being prioritized, with new training resources being developed to enhance user experience [14] Sales Process Improvements - The company is transitioning to virtual pre-sale demonstrations to streamline the sales cycle and reduce costs associated with on-site visits [17] - A Customer Relationship Management (CRM) system has been implemented to improve lead tracking and sales efficiency [16] Partnerships and Collaborations - Ventripoint is actively engaging with healthcare partners and industry advisors to enhance clinical innovation and establish strategic collaborations [12][28] - The company is pursuing opportunities in international markets, including China and India, to expand its distribution and manufacturing capabilities [26][27] Product Development and Manufacturing - Significant investments have been made in product development, with a focus on improving integration into clinical workflows and enhancing automation [31][33] - The production process for new magnet-free sensors has been upgraded, and quality standards are being met or exceeded [31][32] Financial Overview - The company has closed several private placements to support growth and maintain operations while avoiding unnecessary dilution [34] - Ventripoint is working with investment bankers to secure additional capital and increase market awareness [35] Strategic Priorities - The company is focused on achieving commercial traction, supporting clinical innovation, developing compelling ROI models, enhancing platform capabilities, and pursuing strategic collaborations [41]

   Calgary, Alberta – TheNewswire - October 24, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce it will be presenting at the Centurion One Capital 3rd Annual Bahamas Summit, a two day invitation only event taking place at the exclusive Rosewood Baha Mar Hotel from Tuesday, October 28th to Wednesday, October 29th, 2025, in Nassau, Bahamas.  Dean Burns, President and CEO of Ocumetics, w ...

Core Insights - Vanguard Mining Corp. supports the Canadian government's announcement of over $3 billion in investments for the Darlington New Nuclear Project, marking a significant step towards Canada's first grid-scale Small Modular Reactor initiative [1][2][3] Company Overview - Vanguard Mining Corp. is a Canadian exploration company focused on uranium supply, aligning its strategy with Canada's clean energy objectives and the development of a resilient nuclear fuel supply chain [2][8] Market Dynamics - The uranium market is experiencing increased demand and investor confidence, with exploration companies in Canada's Athabasca Basin raising over US$1.2 billion in 2025 to support new discoveries [3][4][6] - The global uranium outlook is tightening, with projected demand expected to double by 2040, while the U.S. Energy Information Administration warns of a potential 184-million-pound shortfall over the next decade if new projects are not developed [4][6] Strategic Importance - The current environment of escalating demand and constrained supply presents a unique opportunity for Vanguard Mining to advance domestic uranium projects and help address the emerging supply gap [6] - The Athabasca Basin is highlighted as a critical region for Canada's uranium future, essential for meeting global clean energy goals [6]

Core Insights - Voyageur Pharmaceuticals Ltd. is expanding its board of directors by appointing two experienced Wall Street executives to enhance its access to U.S. capital markets and attract American investments for growth in the diagnostic imaging sector [1][2][3] Board Expansion - The new directors possess extensive experience in U.S. public offerings, capital raises, and regulatory compliance, which will help Voyageur transition from the TSX Venture Exchange to the U.S. markets [2][3] - Jeffrey J. Kraws has over 35 years of experience in leading capital raises and IPOs for pharmaceutical firms, expected to leverage his network to enhance Voyageur's equity story [3][6] - Christopher A. Van Buren brings over three decades of leadership experience and expertise in risk management, which will strengthen Voyageur's governance and compliance with U.S. regulations [4][6] Strategic Vision - The board expansion aligns with Voyageur's goal of becoming the first contrast media company with a secure supply chain of domestically produced products, ensuring long-term supply chain security for North America [5] - Voyageur is advancing its feasibility studies for the Frances Creek Barium Contrast project and the Oklahoma iodine feasibility study, aiming to become a vertically integrated radiology drug company [5][12] Business Model - Voyageur focuses on developing high-performance barium and iodine Active Pharmaceutical Ingredients (API) for imaging contrast agents, with plans to transition into a high-margin domestic manufacturer [9][10] - The company aims to control all primary input costs from sourcing raw materials to final production, embodying the "Earth to Bottle" strategy to ensure quality and cost efficiency [12][11]

Core Viewpoint - Tribeca Resources Corporation successfully closed a non-brokered private placement offering, raising approximately $6.49 million by issuing 30,903,183 units at a price of $0.21 per unit, indicating strong investor interest and support for the company's growth strategy in copper exploration assets in Chile [1][2]. Financing Details - The offering consisted of units, each comprising one common share and one-half of a common share purchase warrant, with warrants exercisable at $0.30 within the first year and $0.40 in the second year [2]. - The total gross proceeds from the offering amounted to $6,489,668.43 [1]. Use of Proceeds - The proceeds will primarily fund the La Higuera IOCG project, with additional allocations for initial exploration and drilling at the Jiguata Project [4][5]. - Estimated allocation of funds includes: - $1,868,000 for La Higuera Project exploration - $1,573,000 for Jiguata Project exploration - $1,331,000 for follow-up drilling at both projects - $181,000 for business development - $894,000 for general and administrative expenses - $382,000 for unallocated working capital - Total estimated allocation: $6,229,000 [5]. Regulatory and Insider Participation - The offering was conducted under the listed issuer financing exemption, meaning the securities are not subject to a hold period under Canadian securities laws [3]. - Certain insiders subscribed for approximately $936,046 worth of units, qualifying as a related party transaction, but no new insiders or changes in control occurred as a result [10]. Company Overview - Tribeca Resources focuses on copper exploration in northern Chile, aiming to develop a portfolio of mid to advanced-stage copper projects [12][13]. - The flagship property, La Higuera Project, spans 4,147 hectares and is located in the Chilean Coastal IOCG Belt [14].